Trial evidence: Tesamorelin 2mg SC daily sustained GH/IGF-1 elevation, 15-18% visceral fat reduction over 6 months (Falutz, NEJM 2007, PMID 17699044) Ipamorelin 200-300 mcg peak GH 5-10x baseline within 30 minutes, no cortisol/prolactin bump (Raun, EJE 1998, PMID 9539826) GHRH + GHRP synergy 2-3x greater amplitude than either alone (Bowers, JCEM 1991, PMID 2004615) Community protocols extend this evidence base with cycling patterns that weren't studied in the original trials the 5-on/2-off rhythm and 8-week cycles are empirical community consensus, not clinically validated
Colah S, Trauner DA (1997) Tactile recognition in infantile nephropathic cystinosis
These microorganisms also produce substances that create an environment favorable for other beneficial bacteria to flourish
51 The dose/concentration employed, the selected target tissue, the experimental models, as well as medicational interactions that may have positive or negative effects on the bodys redox state all influence the promotion of antioxidant effects by retinoid compounds in cell lines or living organisms
